160 related articles for article (PubMed ID: 11961573)
21. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
22. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
23. Erythrocytosis and hyperlipemia as manifestations of hepatic carcinoma.
Santer MA; Waldmann TA; Fallon HJ
Arch Intern Med; 1967 Dec; 120(6):735-9. PubMed ID: 4293747
[No Abstract] [Full Text] [Related]
24. [Primary hepatic cancer and polyglobulism: review of literature and presentation of a personal case].
Pagnan A
Minerva Med; 1970 Mar; 61(18):865-71. PubMed ID: 4313754
[No Abstract] [Full Text] [Related]
25. [Paraneoplastic syndrome of hepatocellular carcinoma].
Tagawa K; Uta Y
Ryoikibetsu Shokogun Shirizu; 1995; (7):453-5. PubMed ID: 8749523
[No Abstract] [Full Text] [Related]
26. [Erythrocytosis in primary cancer of the liver].
Zlatkina AR; Shcherbak EM
Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):55-6. PubMed ID: 4319483
[No Abstract] [Full Text] [Related]
27. Undetected hepatocellular carcinoma in patients undergoing liver transplantation: is associated with favorable outcome.
Urahashi T; Lynch SV; Kim YH; Balderson GA; Fawcett JW; Crawford DH; Strong RW
Hepatogastroenterology; 2007 Jun; 54(76):1192-5. PubMed ID: 17629068
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary study on orthotopic liver transplantation for treatment of advanced hepatocellular carcinoma without extra-hepatic metastasis - a report of 10 cases].
Yuan YF; Cui BK; Zhang YQ; Li SP; Chen MS; Guo RP; Lin XJ; Chen GH; Li JQ
Ai Zheng; 2004 Sep; 23(9):981-4. PubMed ID: 15363187
[TBL] [Abstract][Full Text] [Related]
30. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
31. [Paraneoplasic erythrocytosis].
Galiana Martín D; Suárez González A; Arias Miranda I; León Durán D
An Med Interna; 2005 Sep; 22(9):455-6. PubMed ID: 16397955
[No Abstract] [Full Text] [Related]
32. [Primary liver carcinoma and polyglobulia].
Haas P; Hell E
Med Klin; 1970 May; 65(18):880-2. PubMed ID: 4323754
[No Abstract] [Full Text] [Related]
33. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence.
Moore SW; Millar AJ; Hadley GP; Ionescu G; Kruger M; Poole J; Stones D; Wainwright L; Chitnis M; Wessels G
Cancer; 2004 Aug; 101(3):642-9. PubMed ID: 15274079
[TBL] [Abstract][Full Text] [Related]
35. Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression.
Sun W; Kosyna FK; Jelkmann W; Depping R
Cell Physiol Biochem; 2015; 37(6):2257-64. PubMed ID: 26624507
[TBL] [Abstract][Full Text] [Related]
36. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
37. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
[TBL] [Abstract][Full Text] [Related]
38. Erythrocytosis in a patient with hepatocellular carcinoma.
Trotter JF; Cohn A; Grant R
J Clin Gastroenterol; 2002 Oct; 35(4):365-6. PubMed ID: 12352309
[No Abstract] [Full Text] [Related]
39. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
